All In MedTech

FDA Clearance Tracker · P050017-S024

Zilver Flex(R) 35 Vascular Stent

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 1, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 1, 2025

Approved

Time to decision

277 days

Received Sep 27, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P050017-S024
Device name
Zilver Flex(R) 35 Vascular Stent
Applicant location
Limerick
Received
Sep 27, 2024
Decided
Jul 1, 2025
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P050017

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

The Zilver Flex® 35 Vascular Stent is intended to improve the luminal diameter in the treatment of de novo or restenotic symptomatic lesions in the native above-the-knee femoropopliteal arteries with reference vessel diameters from 4 to 7 mm and lesion lengths up to 190 mm

Source documents

Other decisions for Cook Ireland, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.